Nov. 14 (UPI) -- Researchers have developed a microbicide gel formula that has shown potential to prevent sexual transmission of human immunodeficiency virus (HIV).
The gel has shown promise for vaginal and rectal administration. The team, which includes the research team at ImQuest BioSciences, Duke University and University of Pittsburgh, created this safe gel which goes beyond current products which are only for vaginal administration.